Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy
(2010)
Journal Article
Hows, J., Wexler, S., Kemp, K. C., Morse, R., Wexler, S. A., Cox, C., …Donaldson, C. (2010). Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Annals of Hematology, 89(7), 701-713. https://doi.org/10.1007/s00277-009-0896-2
Hematopoietic recovery after high-dose chemotherapy (HDC) in the treatment of hematological diseases may be slow and/or incomplete. This is generally attributed to progressive hematopoietic stem cell failure, although defective hematopoiesis may be i... Read More about Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.